Dr. Strawn is an Associate Professor of Psychiatry, Pediatrics and Clinical Pharmacology at the University of Cincinnati. He directs the University of Cincinnati Anxiety Disorders Research Program and is the Associate Vice Chair of Research in the Department of Psychiatry & Behavioral Neuroscience.

​

Dr. Strawn earned his M.D. from the University of Cincinnati and then completed general psychiatry residency training at the UC and a clinical fellowship in child and adolescent psychiatry at Cincinnati Children’s Hospital.

​

His research focuses on anxiety disorders and risk factors for these conditions as well as on the treatment of these disorders. With his collaborators, Dr. Strawn uses brain imaging, pharmacogenetics and pharmacologic approaches to identify early predictors of treatment response and tolerability in anxiety disorders. His work broadly aims to identify the best treatments for individual patients based on patient-specific characteristics and to characterize the patterns of improvement. This body of work has provided a platform for refining treatment targets and identifying biomarkers of treatment response biomarkers in anxiety and related disorders.

​

In his clinical practice, he works with patients with anxiety and related disorders and with their families and supervises residents and fellows. Dr. Strawn has authored more than 150 peer-reviewed publications and co-authored two textbooks on the treatment of children and adolescents and on contemporary psychotherapy. In his spare time, he enjoys spending time with his wife and twin daughters, being outdoors and cooking.

Dr. Ramsey is a pharmacogeneticist at Cincinnati Children’s Hospital Medical Center in the Pharmacy Research group of the Division of Research in Patient Services. She works closely with the Divisions of Human Genetics, Clinical Pharmacology, and the Division of Child Psychiatry. Dr. Ramsey employs pharmacogenetics approaches in clinical and translational studies. She is an active member of the Clinical Pharmacogenetics Implementation Consortium, authoring guidelines on PGx-guided treatment. As part of an ongoing collaboration to evaluate PGx predictors of treatment response in pediatric patients,   

Dr. Ramsey is the Co-Director of the Genetic Pharmacology Service (GPS), which offers pharmacogenetic tests to patients and provides interpretation of results and has, at CCHMC, led the charge for updating the current psychiatry pharmacogenetic test, which is performed routinely on patients admitted to the psychiatry unit at CCHMC. She is keen to investigate whether pharmacogenetically-guided treatment of antidepressants influences treatment response in our pediatric population with anxiety disorders at the start of outpatient care.  

Jeff Mills is Associate Professor of Economics at the University of Cincinnati. He has been at the University of Cincinnati since 1992. Dr. Mills has published articles in some of the leading econometrics and applied economics journals, including Journal of Econometrics, Journal of Applied Econometrics, Econometric Reviews, Empirical Economics, and Applied Economics.

​

Dr. Mills received his bachelor's degree in economics at the University of West England, his master's degree in quantitative economics from Bristol University and his PhD in economics from Washington University. Dr. Mills specializes in time series econometrics, Bayesian inference and statistical hypothesis testing.

​

Dr. Mills received the 2006 Fellow of the Midwest Econometrics Group Honor for contributions to the field of econometrics and for continued participation in presenting papers and organizing the Midwest Econometrics Group annual meetings. 

Heidi Schroeder received her bachelor's degree in neuroscience from the University of Cincinnati. She has worked with children and adolescents with anxiety disorders in the Department of Psychiatry and Behavioral Neuroscience since 2013. As a senior clinical research professional, she has helped to develop and implement multiple clinical research studies for patients with depression and anxiety disorders, including those which have used brain imaging and other techniques to predict which treatments will work best for which patients. In her free time, she enjoys spending time with her husband and two toddlers.

Sarah Skoch, PhD is a child and adolescent psychologist with extensive expertise in cognitive behavioral therapy and in pediatric anxiety disorders. She has closely worked with community-based pediatricians in the past and will work closely with the community-based psychotherapists who provide clinical care for the patients at the Cincinnati hub. She has a strong and long-standing interest in evidence-based psychotherapies and in developing and optimizing CBT approaches.

Zoe Neptune received her bachelor's degree in business administration from the Ohio State University. She has worked with children and adolescents with anxiety disorders in the Department of Psychiatry and Behavioral Neuroscience since 2021. As a senior clinical research professional, she has helped to develop and implement multiple clinical research studies for patients with depression and anxiety disorders. In her free time, she enjoys spending time with her husband and dog. 

Ethan Poweleit is a PhD student in the Biomedical Informatics Graduate Program at the University of Cincinnati and Cincinnati Children’s Hospital under the advisement of Dr. Laura Ramsey. He earned his bachelor’s degree in Biological Sciences from Northern Kentucky University. 

​

Ethan’s research focuses on understanding how pharmacogenetic factors influence treatment outcomes in children and adolescents with anxiety and depression. By leveraging various computational modeling and algorithmic approaches, he aims to characterize and predict response, tolerability, and drug concentrations of psychotropic medications to personalize treatment recommendations for each patient. In his spare time, he enjoys spending time with his family and friends, playing guitar and piano, and cooking. 

Tommy Baumel is a medical student at the University of Cincinnati College of Medicine interested in pursuing child and adolescent psychiatry. He earned his B.A. in Cognitive Neuroscience from Washington University in St. Louis. Tommy’s past research focused on network-based functional connectivity underlying pediatric anxiety disorders. Currently, his research interests focus on the neurofunctional biomarkers of treatment success and treatment-related change in anxiety disorders, and genetic and behavioral modulators of brain activity. In his free time, he can be found playing basketball, kayaking, and enjoying breweries around Cincinnati.